Treatment of acute hepatitis C infection: More pieces of the puzzle?

Journal of Hepatology

Volumn 42, Issue 3, 2005, Pages 293-296

  Zekry, Amany ^a   Patel, Keyur ^a   McHutchison, John G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; PEGINTERFERON; RIBAVIRIN;

CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG DEPENDENCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; DRUG TOLERABILITY; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; MENTAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SIDE EFFECT; TREATMENT OUTCOME;

EID: 13844266084     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.12.012     Document Type: Editorial

References (31)

1. H.J. Alter, and L.B. Seeff Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome Semin Liver Dis 20 2000 17 35
2. J.B. Wong, G.M. McQuillan, J.G. McHutchison, and T. Poynard Estimating future hepatitis C morbidity, mortality, and costs in the United States Am J Public Health 90 2000 1562 1569
3. E. Jaeckel, M. Cornberg, H. Wedemeyer, T. Santantonio, J. Mayer, and M. Zankel Treatment of acute hepatitis C with interferon alfa-2b N Engl J Med 345 2001 1452 1457
4. J.T. Gerlach, H.M. Diepolder, R. Zachoval, N.H. Gruener, M.C. Jung, and A. Ulsenheimer Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance Gastroenterology 125 2003 80 88
5. H. Hofer, T. Watkins-Riedel, O. Janata, E. Penner, H. Holzmann, and P. Steindl-Munda Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load Hepatology 37 2003 60 64
6. S.M. Kamal, A. Ismail, C.S. Graham, Q. He, J.W. Rasenack, and T. Peters Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics Hepatology 39 2004 1721 1731
7. H. Nomura, S. Sou, H. Tanimoto, T. Nagahama, Y. Kimura, and J. Hayashi Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial Hepatology 39 2004 1213 1219
8. N.R. Pimstone, D. Pimstone, T. Saicheur, J. Powell, and A.S. Yu Wait-and-see: an alternative approach to managing acute hepatitis C with high-dose interferon-alpha monotherapy Ann Intern Med 141 2004 W91 W92
9. P. Rocca, F. Bailly, M. Chevallier, P. Chevallier, F. Zoulim, and C. Trepo Early treatment of acute hepatitis C with interferon alpha-2b or interferon alpha-2b plus ribavirin: study of sixteen patients Gastroenterol Clin Biol 27 2003 294 299
10. J. Wiegand, W. Boecher, P. Buggisch, S. Zeuzem, C. Gelfmann, and M. Cornberg 24 weeks of monotherapy with pegylated interferon alfa-2b in patients with acute hepatitis C infection Hepatology 38 2003 277A
11. T. Santantonio, M. Fasano, E. Sinisi, A. Guastadisegni, C. Casalino, and M. Mazzola Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance J Hepatol 42 2005 329 333
12. B. Broers, B. Helbling, A. François, P. Schmid, C. Chuard, and A. Hadengue Barriers to interferon α therapy are higher in intravenous drug users than in other patients with acute hepatitis C J Hepatol 42 2005 323 328
13. J. Delwaide, N. Bourgeois, C. Gerard, S. De Maeght, F. Mokaddem, and E. Wain Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response Aliment Pharmacol Ther 20 2004 15 22
14. J. Wiegand, E. Jackel, M. Cornberg, H. Hinrichsen, M. Dietrich, and J. Kroeger Long-term follow-up after successful interferon therapy of acute hepatitis C Hepatology 40 2004 98 107
15. Statement on Management of Hepatitis C: 2002 NIH Consens State Sci Statements 19 2002 1 46
16. R. Wejstal, A. Alaeus, B. Fischler, O. Reichard, I. Uhnoo, and O. Weiland Chronic hepatitis C: updated Swedish consensus Scand J Infect Dis 35 2003 445 451
17. Treatment of hepatitis C Paris 27-28 February 2002 Ann Med Interne (Paris) 153 2002 467 477
18. M.J. Alter, S.C. Hadler, F.N. Judson, A. Mares, W.J. Alexander, and P.Y. Hu Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection J Am Med Assoc 264 17 1990 2231 2235
19. M. Schaefer, F. Schmidt, C. Folwaczny, R. Lorenz, G. Martin, and N. Schindlbeck Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups Hepatology 37 2003 443 451
20. D.L. Sylvestre, J.M. Loftis, P. Hauser, S. Genser, H. Cesari, and N. Borek Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care J Urban Health 81 2004 719 734
21. B.H. Lerner, R.M. Gulick, and N.N. Dubler Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease Ann Intern Med 129 1998 573 578
22. S. Mauss, F. Berger, J. Goelz, B. Jacob, and G. Schmutz A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance Hepatology 40 2004 120 124
23. G.L. Davis, and J.R. Rodrigue Treatment of chronic hepatitis C in active drug users N Engl J Med 345 2001 215 217
24. M. Cournot, A. Glibert, F. Castel, F. Druart, K. Imani, and V. Lauwers-Cances Management of hepatitis C in active drugs users: experience of an addiction care hepatology unit Gastroenterol Clin Biol 28 2004 533 539
25. L.A. Kondili, P. Chionne, A. Costantino, U. Villano, C. Lo Noce, and F. Pannozzo Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population Gut 50 2002 693 696
26. H. Wedemeyer, E. Jackel, J. Wiegand, M. Cornberg, and M.P. Manns Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C Hepatology 39 2004 1201 1203
27. A. Licata, D. Di Bona, F. Schepis, L. Shahied, A. Craxi, and C. Camma When and how to treat acute hepatitis C? J Hepatol 39 2003 1056 1062
28. E. Jaeckel, H. Wedemeyer, J. Wiegand, and M.P. Manns Acute hepatitis C virus infection: to treat or not to treat? Gastroenterology 126 2004 1219 1220 [author reply 20]
29. M. Manns, S. Meyer, and H. Wedemeyer The German Network of excellence for viral hepatitis (Hep-Net) Hepatology 38 2003 543 544
30. J.T. Gerlach, H. Diepolder, and G.R. Pape Acute hepatitis C virus infection: to treat or not to treat? Gastroenterolgy 126 2004 1220 [author reply]
31. G. Calleri, F. Gaiottino, G. Leo, S. Belloro, P. Romano, and G. Dalmasso Short course of Pegylated interferon alfa-2b in acute HCV hepatitis J Hepatol 40 2004 469